<?xml version='1.0' encoding='UTF-8'?>
<PolymerNanocomposite><PDB_ID>1T4V</PDB_ID><DATA_SOURCE><Citation><CitationType>research article</CitationType><Publication>Bioorganic &amp; Medicinal Chemistry Letters</Publication><Title>Oxyguanidines. Part 2: Discovery of a novel orally active thrombin inhibitor through structure-based drug design and parallel synthesis</Title><Author>Lu, Tianbao</Author><Author>Markotan, Thomas</Author><Author>Coppo, Frank</Author><Author>Tomczuk, Bruce</Author><Author>Crysler, Carl</Author><Author>Eisennagel, Stephen</Author><Author>Spurlino, John</Author><Author>Gremminger, Lisa</Author><Author>Soll, Richard M</Author><Author>Giardino, Edward C</Author><Author>Bone, Roger</Author><Publisher>Elsevier</Publisher><PublicationYear>2004</PublicationYear><DOI>10.1016/j.bmcl.2004.05.002</DOI><Volume>14</Volume><Issue>14</Issue></Citation></DATA_SOURCE><MATERIALS><Matrix><MatrixComponent><ChemicalName>Prothrombin</ChemicalName><MacroMoleculeClass>HYDROLASE/HYDROLASE INHIBITOR</MacroMoleculeClass><MacroMoleculeType>Protein</MacroMoleculeType><ManufacturerOrSourceName>Homo sapiens</ManufacturerOrSourceName><MolecularWeight><value>34742.11</value></MolecularWeight></MatrixComponent></Matrix></MATERIALS><CHARACTERIZATION><XRay_Diffraction_and_Scattering><Equipment>ENRAF-NONIUS FR571 RIGAKU RAXIS II</Equipment><Description>Resolution: 2.0</Description></XRay_Diffraction_and_Scattering></CHARACTERIZATION><PROPERTIES><Biological><Sequence>IVEGSDAEIGMSPWQVMLFRKSPQELLCGASLISDRWVLTAAHCLLYPPWDKNFTENDLLVRIGKHSRTRYERNIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHPVCLPDRETAASLLQAGYKGRVTGWGNLKETWTANVGKGQPSVLQVVNLPIVERPVCKDSTRIRITDNMFCAGYKPDEGKRGDACEGDSGGPFVMKSPFNNRWYQMGIVSWGEGCDRDGKYGFYTHVFRLKKWIQKVIDQFGE</Sequence><SpaceGroup>C 1 2 1</SpaceGroup></Biological></PROPERTIES></PolymerNanocomposite>